Polymeric biomaterials have become a focal point in medical innovation, offering personalized solutions for implants, scaffolds, and drug delivery. Driven by rising demand for minimally invasive procedures, the market is expected to surpass US$16 billion by 2030, reshaping clinical care worldwide.